UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000023534 |
|---|---|
| Receipt number | R000027104 |
| Scientific Title | Screenig for Fabry disease in renal transplant patients(Monitoring of mulberry body and mulberry cell) |
| Date of disclosure of the study information | 2016/08/08 |
| Last modified on | 2016/08/08 01:59:55 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Screenig for Fabry disease in renal transplant patients(Monitoring of mulberry body and mulberry cell)
Acronym
Screenig for Fabry disease in renal transplant patients(Monitoring of mulberry body and mulberry cell)
Scientific Title
Screenig for Fabry disease in renal transplant patients(Monitoring of mulberry body and mulberry cell)
Scientific Title:Acronym
Screenig for Fabry disease in renal transplant patients(Monitoring of mulberry body and mulberry cell)
Region
| Japan |
Condition
Condition
Fabry disease
Classification by specialty
| Medicine in general | Endocrinology and Metabolism | Nephrology |
| Urology |
Classification by malignancy
Others
Genomic information
YES
Objectives
Narrative objectives1
To evaluate the usefulness of mulberry body and mulberry cell as screening test for Fabry disease in renal transplant recipients
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
mulberry body, mulberry cell, alpha-galactosidase A activity
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
renal transplant patients gave written informed consent to participate in the study
Key exclusion criteria
None
Target sample size
150
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Ayumi Funabiki |
Organization
Takatsuki General Hospital
Division name
Endocrinology and Metabolism
Zip code
Address
1-3-13, Kosobe-cho, Takatsuki, Osaka, Japan
TEL
072-681-3801
funabiki@ajk.takatsuki-hp.or.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Ayumi Funabiki |
Organization
Takatsuki General Hospital
Division name
Endocrinology and Metabolism
Zip code
Address
1-3-13, Kosobe-cho, Takatsuki, Osaka, Japan
TEL
072-681-3801
Homepage URL
funabiki@ajk.takatsuki-hp.or.jp
Sponsor or person
Institute
Takatsuki General Hospital
Institute
Department
Personal name
Funding Source
Organization
none
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2016 | Year | 08 | Month | 08 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Enrolling by invitation
Date of protocol fixation
| 2016 | Year | 06 | Month | 28 | Day |
Date of IRB
Anticipated trial start date
| 2016 | Year | 08 | Month | 08 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
To evaluate the usefulness of mulberry body and mulberry cell as screening test for Fabry disease in renal transplant patients
Management information
Registered date
| 2016 | Year | 08 | Month | 08 | Day |
Last modified on
| 2016 | Year | 08 | Month | 08 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027104
